VOLUNTARY ANNOUNCEMENT PHASE III CLINICAL STUDY RESULTS OF OTURKIBART (QX005N) FOR TREATMENT OF PRURIGO NODULARIS PRESENTED AS A LATE-BREAKING ORAL PRESENTATION AT EADV 2026
02509 Qyuns Therapeutics Co., Ltd.QYUNS-BHong Kong Stock Exchange
4 posts
Qyuns Therapeutics Co., Ltd. (02509) at a glance
Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.
Qyuns Therapeutics Co., Ltd. (02509) Stock Price History
Qyuns Therapeutics Co., Ltd. closed at HK$16.56 on Oct 22, 2026, −2.6% over 1 month, −43.4% over 1 year.
If you had invested HK$10,000 1 month ago, it would be worth HK$9,741 today (−2.6%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved −8.6%, while this stock moved −2.6%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Oct 22 (Thu) | HK$16.56 | −0.18 | −1.08% |
| Oct 21 (Wed) | HK$16.74 | +0.54 | +3.33% |
| Oct 20 (Tue) | HK$16.20 | +0.20 | +1.25% |
| Oct 16 (Fri) | HK$16.00 | +0.50 | +3.23% |
| Oct 15 (Thu) | HK$15.50 | −0.52 | −3.25% |
| Oct 14 (Wed) | HK$16.02 | −0.40 | −2.44% |
| Oct 13 (Tue) | HK$16.42 | −0.34 | −2.03% |
| Oct 12 (Mon) | HK$16.76 | −0.24 | −1.41% |
| Oct 9 (Fri) | HK$17.00 | +0.00 | +0.00% |
| Oct 8 (Thu) | HK$17.00 | −0.29 | −1.68% |
If you had invested HK$10,000 3 months ago, it would be worth HK$10,395 today (+4.0%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved −7.9%, while this stock moved +4.0%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Oct 22 (Thu) | HK$16.56 | −0.18 | −1.08% |
| Oct 21 (Wed) | HK$16.74 | +0.54 | +3.33% |
| Oct 20 (Tue) | HK$16.20 | +0.20 | +1.25% |
| Oct 16 (Fri) | HK$16.00 | +0.50 | +3.23% |
| Oct 15 (Thu) | HK$15.50 | −0.52 | −3.25% |
| Oct 14 (Wed) | HK$16.02 | −0.40 | −2.44% |
| Oct 13 (Tue) | HK$16.42 | −0.34 | −2.03% |
| Oct 12 (Mon) | HK$16.76 | −0.24 | −1.41% |
| Oct 9 (Fri) | HK$17.00 | +0.00 | +0.00% |
| Oct 8 (Thu) | HK$17.00 | −0.29 | −1.68% |
If you had invested HK$10,000 6 months ago, it would be worth HK$8,288 today (−17.1%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved −12.3%, while this stock moved −17.1%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Oct 2026 | HK$16.56 | −2.3% |
| Sep 2026 | HK$16.95 | +1.7% |
| Aug 2026 | HK$16.66 | +2.2% |
| Jul 2026 | HK$16.30 | +15.0% |
| Jun 2026 | HK$14.18 | −15.9% |
| May 2026 | HK$16.86 | −2.0% |
| Apr 2026 | HK$17.20 | −9.9% |
If you had invested HK$10,000 1 year ago, it would be worth HK$5,663 today (−43.4%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved −11.0%, while this stock moved −43.4%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Oct 2026 | HK$16.56 | −2.3% |
| Sep 2026 | HK$16.95 | +1.7% |
| Aug 2026 | HK$16.66 | +2.2% |
| Jul 2026 | HK$16.30 | +15.0% |
| Jun 2026 | HK$14.18 | −15.9% |
| May 2026 | HK$16.86 | −2.0% |
| Apr 2026 | HK$17.20 | −9.9% |
| Mar 2026 | HK$19.08 | +12.4% |
| Feb 2026 | HK$16.97 | −18.6% |
| Jan 2026 | HK$20.86 | +9.2% |
| Dec 2025 | HK$19.10 | −15.2% |
| Nov 2025 | HK$22.52 | +3.4% |
| Oct 2025 | HK$21.78 | ― |
If you had invested HK$10,000 3 years ago, it would be worth HK$7,905 today (−21.0%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved +39.0%, while this stock moved −21.0%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | HK$16.56 | −13.3% |
| 2025 | HK$19.10 | ― |
Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Mar 2024). Please check the latest prices before trading.
Posts
This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.
VOLUNTARY ANNOUNCEMENT PHASE III CLINICAL STUDY RESULTS OF OTURKIBART (QX005N) FOR TREATMENT OF PRURIGO NODULARIS PRESENTED AS A LATE-BREAKING ORAL PRESENTATION AT EADV 2026
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Delete
CONTINUING CONNECTED TRANSACTIONS IN RELATION TO THE REVISION OF ANNUAL CAPS FOR THE QX001S FRAMEWORK AGREEMENT; AND RESIGNATION AND PROPOSED APPOINTMENT OF NON-EXECUTIVE DIRECTOR
Delete
2026 INTERIM REPORT
Delete
Write on the Qyuns Therapeutics Co., Ltd. board
More Chinese stocks in English
- T.S. Lines Limited02510
- HighTide Therapeutics, Inc.02511
- Cloud Factory Technology Holdings Limited02512
- Z.AI Co., Ltd.02513
- Tianjin Construction Development Group Co., Ltd.02515
- FAR International Holdings Group Company Limited02516
- GUOQUAN FOOD (SHANGHAI) CO., LTD.02517
- Autohome Inc.02518
- AuGroup (SHENZHEN) Cross-Border Business Co., Ltd.02519
- Shanxi Installation Group Co., Ltd.02520
- Shenghui Cleanness Group Holdings Limited02521
- Jiangxi Rimag Group Co., Ltd.02522